Clinical trial Recruiting at 9 sites Observational Ages 18 to 50

Identifying genetic factors in recurrent pregnancy loss

Official title: Large Scale Genome Sequencing and Integrative Analyses to Define Genomic Predictors of Recurrent Pregnancy Loss

Run by Yale University · NCT05444283 · Data updated 2026-11-12

This study is trying to find out if certain genetic factors are linked to recurrent pregnancy loss by looking at DNA from families who have experienced this issue.

Quick facts

Study typeObservational
Ages18 Years to 50 Years
SexAll
Enrollment500 (estimated)
SponsorYale University
Academic / other
Locations10 sites (Aurora, Colorado and 9 other locations)
StatusRecruiting
StartedSeptember 1, 2021
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedMay 22, 2026
Trial IDNCT05444283 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are women who have experienced recurrent pregnancy loss and have a current singleton pregnancy that is euploid.

Probably not a fit

Patients with known causes of pregnancy loss, such as karyotype abnormalities or autoimmune diseases, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore the genetic basis of recurrent pregnancy loss (RPL) by collecting and analyzing DNA samples from trios consisting of the product of conception, the biological mother, and the biological father. The study will recruit 1,000 rigorously characterized trios with unexplained RPL and perform whole genome sequencing at the Yale Center for Genome Analysis. The goal is to identify pathogenic genetic variants that could lead to novel gene discoveries and the development of clinical diagnostic tests for RPL.

Why it matters

Potential benefit: If successful, this study could provide insights into the genetic causes of recurrent pregnancy loss, leading to better diagnostic tools and treatment options for affected patients.

How similar studies have gone: Other studies have shown promise in identifying genetic factors related to pregnancy loss, but this specific approach is novel in its comprehensive genomic analysis of trios.

Who can join: the full rules

Show full inclusion / exclusion criteria
Cohort A - Fetal Intolerome Cohort

Inclusion Criteria:

* Women with loss of a current singleton pregnancy at \< 20 0/7 weeks gestation, documented by ultrasonography or histopathological examination
* History of one or more prior pregnancy losses
* Euploid current pregnancy confirmed by karyotype, microarray, or STORK (Short-read Transpore Rapid Karyotyping) sequencing Note: A limited number of aneuploid losses will be included as part of the pilot phase

Exclusion Criteria:

* History of parental karyotype abnormalities
* History of antiphospholipid antibody syndrome
* Evidence of uncontrolled diabetes
* Evidence of uncontrolled thyroid disease
* History of autoimmune disease related to pregnancy loss (e.g., systemic lupus erythematosus, rheumatoid arthritis)
* History of uterine anomalies
* History of cervical insufficiency

Cohort B - Maternal Effect Gene Cohort

Inclusion Criteria:

\- Women with a history of three or more pregnancy losses of unknown cause, with or without a liveborn child

Exclusion Criteria:

\- Known etiology for pregnancy loss

Where it's running

  • University of Colorado
    Aurora, Colorado, United States
    Recruiting
  • Yale University
    New Haven, Connecticut, United States
    Recruiting
  • Northwestern University
    Chicago, Illinois, United States
    Recruiting
  • Johns Hopkins University
    Baltimore, Maryland, United States
    Recruiting
  • Wayne State University
    Detroit, Michigan, United States
    Recruiting
  • Columbia University
    New York, New York, United States
    Recruiting
Show 4 more locations
  • Pennsylvania State University
    Hershey, Pennsylvania, United States
    Recruiting
  • University of Texas at Austin
    Austin, Texas, United States
    Recruiting
  • University of Texas at San Antonio
    San Antonio, Texas, United States
    Recruiting
  • University of Chicago
    Chicago, Illinois, United States
    Active not recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.